Article
A small-molecule fusion inhibitor of influenza virus is orally active in mice
7 Mar 2019
Abstract excerpt
Recent characterization of broadly neutralizing antibodies (bnAbs) against influenza virus identified the conserved hemagglutinin (HA) stem as a target for development of universal vaccines and therapeutics. Although several stem bnAbs are being evaluated in clinical trials, antibodies are generally unsuited for oral delivery. Guided by structural knowledge of the interactions and mechanism of anti-stem bnAb...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
